TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.

Jason Chesney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.